PLASMALYTE IN MUSCULOSKELETAL DISORDERS: IMPLICATIONS FOR THE MANAGEMENT OF DORSALGI

Authors

  • Kilum, Y.B. Medical researcher

DOI:

https://doi.org/10.55640/

Keywords:

dorsalgia, back pain, Plasmalyte.

Abstract

Dorsalgia, or back pain, is one of the most common musculoskeletal disorders affecting people of different ages and occupations. Its multifactorial etiology includes degenerative changes, muscular strain, trauma, and metabolic disturbances. Plasmalyte, a balanced isotonic electrolyte solution, has recently been explored for its potential role in improving metabolic homeostasis, reducing muscular ischemia, and enhancing tissue perfusion in patients with dorsalgia. This article analyzes the clinical rationale for using Plasmalyte in dorsalgia management, discussing its physiological benefits, therapeutic indications, and possible implications for improving patient outcomes.

Downloads

Download data is not yet available.

References

1.Mythen, M. G., & Shaw, A. D. (2013). “Anaesthetists should embrace balanced crystalloids.” BMJ, 346, f393.

2.Kellum, J. A., & Lameire, N. (2018). “Balanced crystalloids for critically ill patients.” New England Journal of Medicine, 378(9), 829–839.

3.Hoy, D., et al. (2014). “The global burden of low back pain: estimates from the Global Burden of Disease 2010 study.” Annals of the Rheumatic Diseases, 73(6), 968–974.

4.Raghunathan, K., et al. (2015). “Choice of fluid therapy in the perioperative setting: a review.” Anesthesia & Analgesia, 120(3), 537–549.

5.World Health Organization. (2022). Musculoskeletal conditions fact sheet. Geneva: WHO.

Downloads

Published

2025-09-16

Issue

Vol. 4 No. 8 (2025): Journal of Multidisciplinary Sciences and Innovations

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

How to Cite

PLASMALYTE IN MUSCULOSKELETAL DISORDERS: IMPLICATIONS FOR THE MANAGEMENT OF DORSALGI. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(8), 352-355. https://doi.org/10.55640/

Similar Articles

1-10 of 107

You may also start an advanced similarity search for this article.